Literature DB >> 14010673

The action of guanethidine with particular reference to the sympathetic nervous system.

G F ABERCROMBIE, B N DAVIES.   

Abstract

It has been suggested that guanethidine can release and then deplete postganglionic sympathetic nerve endings of noradrenaline. However, no release of noradrenaline from postganglionic nerve endings or from the adrenal medulla by guanethidine was found by direct experiment. Although release of noradrenaline from postganglionic sympathetic nerve endings in response to nerve stimulation was rapidly reduced and finally abolished by guanethidine, the drug did not appear to affect the release of catechol amines from the adrenal medulla in response to splanchnic nerve stimulation. The nature of the action of guanethidine is discussed, and it is concluded that it blocks the effect of postganglionic sympathetic nerve stimulation by interfering with the synthesis of transmitter and that it also has a direct sympathomimetic effect.

Entities:  

Keywords:  GUANETHIDINE; SYMPATHETIC NERVOUS SYSTEM

Mesh:

Substances:

Year:  1963        PMID: 14010673      PMCID: PMC1703743          DOI: 10.1111/j.1476-5381.1963.tb01307.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  7 in total

1.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

2.  The initial pressor actions of bretylium tosylate and guanethidine sulfate and their relation to release of catecholamines.

Authors:  C N GILLIS; C W NASH
Journal:  J Pharmacol Exp Ther       Date:  1961-10       Impact factor: 4.030

3.  The effect of neuronal rest on the output of sympathetic transmitter from the spleen.

Authors:  G L BROWN; B N DAVIES; C B FERRY
Journal:  J Physiol       Date:  1961-12       Impact factor: 5.182

4.  Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).

Authors:  R A MAXWELL; A J PLUMMER; F SCHNEIDER; H POVALSKI; A I DANIEL
Journal:  J Pharmacol Exp Ther       Date:  1960-01       Impact factor: 4.030

5.  The output of sympathetic transmitter from the spleen of the cat.

Authors:  G L BROWN; J S GILLESPIE
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

6.  Tissue amine levels and sympathetic blockade after guanethidine and bretylium.

Authors:  R CASS; T L SPRIGGS
Journal:  Br J Pharmacol Chemother       Date:  1961-12

7.  Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent.

Authors:  R CASS; R KUNTZMAN; B B BRODIE
Journal:  Proc Soc Exp Biol Med       Date:  1960-04
  7 in total
  13 in total

1.  Blood pressure responses to adrenal field stimulation as a measure of adrenal catecholamine release.

Authors:  D E Clarke; W M Romanyshyn
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

2.  Modification of pressor effects of some vasoactive polypeptides in the rat by guanethidine propranolol and related agents.

Authors:  E Miele; G De Natale
Journal:  Br J Pharmacol Chemother       Date:  1967-01

3.  The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits.

Authors:  B M Johnson
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

4.  Sympathetic control of lower esophageal sphincter function in the cat. Action of direct cervical and splanchnic nerve stimulation.

Authors:  J Fournet; W J Snape; S Cohen
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

5.  The action of guanethidine on the adrenal medulla of the cat.

Authors:  S D Jaanus; E Miele; R P Rubin
Journal:  Br J Pharmacol Chemother       Date:  1968-07

Review 6.  A review: the agents and actions of sympathetic nerve and catecholamine inhibition of gastric mucosal function.

Authors:  D J Sanders
Journal:  Agents Actions       Date:  1976-07

7.  A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-beta-hydroxyphenethylguanidine.

Authors:  R Fielden; A L Green
Journal:  Br J Pharmacol Chemother       Date:  1967-05

8.  Studies on the interactions of guanethidine and bretylium with noradrenaline stores.

Authors:  C C Chang; J C Chang; C Y Su
Journal:  Br J Pharmacol Chemother       Date:  1967-06

9.  Circulatory control in hypoxia by the sympathetic nerves and adrenal medulla.

Authors:  P I Korner; S W White
Journal:  J Physiol       Date:  1966-05       Impact factor: 5.182

10.  Evidence for a physiological role of presynaptic alpha-adrenoceptors: modulation of noradrenaline release in the pithed rabbit.

Authors:  H Majewski; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.